Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Non-Current Assets (2018 - 2025)

TELA Bio (TELA) has 8 years of Non-Current Assets data on record, last reported at $5.5 million in Q3 2025.

  • For Q3 2025, Non-Current Assets fell 37.65% year-over-year to $5.5 million; the TTM value through Sep 2025 reached $28.3 million, down 15.47%, while the annual FY2024 figure was $8.5 million, 34.44% up from the prior year.
  • Non-Current Assets reached $5.5 million in Q3 2025 per TELA's latest filing, down from $6.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $9.2 million in Q1 2024 and bottomed at $3.1 million in Q2 2021.
  • Average Non-Current Assets over 5 years is $5.9 million, with a median of $5.5 million recorded in 2025.
  • Peak YoY movement for Non-Current Assets: skyrocketed 86.0% in 2022, then plummeted 37.65% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $3.5 million in 2021, then soared by 55.0% to $5.4 million in 2022, then grew by 16.9% to $6.3 million in 2023, then surged by 34.44% to $8.5 million in 2024, then plummeted by 34.83% to $5.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $5.5 million in Q3 2025, $6.8 million in Q2 2025, and $7.5 million in Q1 2025.